U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (XmAb 662)Cat. No. WA2008$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (XmAb 662)Cat. No. WA2008
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (NeuLara)Cat. No. WA2007
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (HAIL-12)Cat. No. WA2006
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (FM202)Cat. No. WA2005
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (DF 6002)Cat. No. WA2004
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (Cephalon 6F6)Cat. No. WA2003
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (CEP-37248)Cat. No. WA2002
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (BOW090)Cat. No. WA2001
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (ART123)Cat. No. WA2000
U-Blot® Research Grade Anti-Human IL12B/IL-12 p40/NKSF2 (ABT-147)Cat. No. WA1999
U-Blot® Research Grade Anti-Human IL11RA Antibody (X209)Cat. No. WA1998
U-Blot® Research Grade Anti-Human IL11RA Antibody (LASN 01)Cat. No. WA1997